BRD8 is a therapeutic vulnerability for overcoming resistance to dual ER/HER2 blockade therapy in HR+/HER2+ breast cancer

.rda file for Seurat object of scRNA-seq data from BT474 breast cancer cell lines treated with DMSO, Neratinib, Fulvestrant, and a combination of Neratinib and Fulvestrant.该.rda文件存储了经二甲基亚砜（Dimethyl sulfoxide, DMSO）、来那替尼（Neratinib）、氟维司群（Fulvestrant）及二者联合给药处理的BT474乳腺癌细胞系的单细胞RNA测序（single-cell RNA sequencing, scRNA-seq）数据对应的Seurat对象（Seurat object）。